Last update 30 Apr 2026

HRS-9813

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
HRS-9813
Target
autotaxin
Action
inhibitors
Mechanism
autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors)
Therapeutic Areas
Respiratory DiseasesOther DiseasesNeoplasms+ [1]
Active Indication
Idiopathic Pulmonary FibrosisProgressive pulmonary fibrosisBreast Cancer
Inactive Indication-
Originator Organization
Guangdong Hengrui Pharmaceutical Co., Ltd.
Active Organization
Guangdong Hengrui Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with HRS-9813
NCT07229716
/ RecruitingPhase 1
Study on the Drug Interactions of HRS-9813, Pirfenidone and Nintedanib in Healthy Subjects
NCT07192939
/ RecruitingPhase 2
Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Trial to Evaluate the Efficacy and Safety of HRS-9813 in Subjects With Pulmonary Fibrosis
NCT06939504
/ CompletedPhase 1
Evaluation of the Relative Bioavailability of HRS-9813 Capsule and Tablet in Healthy Subjects and the Effect of Food on the Pharmacokinetics of HRS-9813 Capsule
100 Clinical Results associated with HRS-9813
Login to view more data
100 Translational Medicine associated with HRS-9813
Login to view more data
100 Patents (Medical) associated with HRS-9813
Login to view more data
100 Deals associated with HRS-9813
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Idiopathic Pulmonary FibrosisPhase 2
China
Guangdong Hengrui Pharmaceutical Co., Ltd.
29 Oct 2025
Progressive pulmonary fibrosisPhase 2
China
Guangdong Hengrui Pharmaceutical Co., Ltd.
29 Oct 2025
Breast CancerIND Approval
China
Guangdong Hengrui Pharmaceutical Co., Ltd.
29 Apr 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free